Ndidiamaka O Obadan1, Rebekah J Walker2, Leonard E Egede3. 1. Department of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, SC. 2. Department of Medicine, Division of General Internal Medicine, Froedtert and The Medical College of Wisconsin, 9200 W. Wisconsin Ave, Milwaukee, WI, USA 53226; Center for Patient Care and Outcomes Research, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, USA 53226. 3. Department of Medicine, Division of General Internal Medicine, Froedtert and The Medical College of Wisconsin, 9200 W. Wisconsin Ave, Milwaukee, WI, USA 53226; Center for Patient Care and Outcomes Research, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, USA 53226. Electronic address: legede@mcw.edu.
Abstract
BACKGROUND: Chronic Kidney Disease (CKD) is usually silent until advanced stages. Awareness of CKD is important to mitigate poorer outcomes. This study aims to understand the relationship(s) between CKD self-awareness and diagnosed CKD. METHODS: The study included 345 adults with type 2 diabetes from two primary care settings. Participants completed surveys assessing demographic information, self-care behaviors and co-morbidities. Biological data were taken from medical records. CKD was diagnosed as eGFR=<59ml/min. CKD awareness was defined by a positive response to "has a doctor, nurse or other health professional ever told you that you have a kidney disease?" and/or "have you ever had kidney failure that required dialysis or a kidney transplant?" Logistic regression models were used to examine the association between CKD awareness and clinical/socio-demographic variables. RESULTS: 31% of study patients had CKD based on eGFR (of which only 63% were aware). Stepwise regression showed that non-Hispanic blacks (OR=3.49, p=0.04), those with college education (OR=8.02, p=0.01), history of myocardial infarction (OR=10.12, p=0.002) or hypertension (OR=23.25, p=0.02), and those with Medicare, VA insurance, or other insurance (OR=8.08, 8.72, 101.47, respectively, p<0.01) were significantly more likely to be aware of CKD. Those with a history of stroke or depression (OR=0.21, 0.28, respectively, p=0.03, p=0.04) were significantly less likely to be aware of CKD. CONCLUSION: CKD awareness was found to be lower than diagnosed CKD rates. Factors associated with awareness include race, educational status and cardiovascular disease. Targeted strategies to increase CKD awareness may lead to improved health outcomes.
BACKGROUND:Chronic Kidney Disease (CKD) is usually silent until advanced stages. Awareness of CKD is important to mitigate poorer outcomes. This study aims to understand the relationship(s) between CKD self-awareness and diagnosed CKD. METHODS: The study included 345 adults with type 2 diabetes from two primary care settings. Participants completed surveys assessing demographic information, self-care behaviors and co-morbidities. Biological data were taken from medical records. CKD was diagnosed as eGFR=<59ml/min. CKD awareness was defined by a positive response to "has a doctor, nurse or other health professional ever told you that you have a kidney disease?" and/or "have you ever had kidney failure that required dialysis or a kidney transplant?" Logistic regression models were used to examine the association between CKD awareness and clinical/socio-demographic variables. RESULTS: 31% of study patients had CKD based on eGFR (of which only 63% were aware). Stepwise regression showed that non-Hispanic blacks (OR=3.49, p=0.04), those with college education (OR=8.02, p=0.01), history of myocardial infarction (OR=10.12, p=0.002) or hypertension (OR=23.25, p=0.02), and those with Medicare, VA insurance, or other insurance (OR=8.08, 8.72, 101.47, respectively, p<0.01) were significantly more likely to be aware of CKD. Those with a history of stroke or depression (OR=0.21, 0.28, respectively, p=0.03, p=0.04) were significantly less likely to be aware of CKD. CONCLUSION: CKD awareness was found to be lower than diagnosed CKD rates. Factors associated with awareness include race, educational status and cardiovascular disease. Targeted strategies to increase CKD awareness may lead to improved health outcomes.
Authors: Delphine S Tuot; Laura C Plantinga; Chi-Yuan Hsu; Regina Jordan; Nilka Ríos Burrows; Elizabeth Hedgeman; Jerry Yee; Rajiv Saran; Neil R Powe Journal: Clin J Am Soc Nephrol Date: 2011-07-22 Impact factor: 8.237
Authors: Thomas F Parker; Roland Blantz; Thomas Hostetter; Jonathan Himmelfarb; Alan Kliger; Michael Lazarus; Allen R Nissenson; Brian Pereira; James Weiss Journal: J Am Soc Nephrol Date: 2004-03 Impact factor: 10.121
Authors: Adam Whaley-Connell; James R Sowers; Peter A McCullough; Tricia Roberts; Samy I McFarlane; Shu-Cheng Chen; Suying Li; Changchun Wang; Allan J Collins; George L Bakris Journal: Am J Kidney Dis Date: 2009-04 Impact factor: 8.860
Authors: A S Levey; R Atkins; J Coresh; E P Cohen; A J Collins; K-U Eckardt; M E Nahas; B L Jaber; M Jadoul; A Levin; N R Powe; J Rossert; D C Wheeler; N Lameire; G Eknoyan Journal: Kidney Int Date: 2007-06-13 Impact factor: 10.612
Authors: Anuja Shah; Linda F Fried; Shu-Cheng Chen; Yang Qiu; Suying Li; Kerri L Cavanaugh; Keith C Norris; Adam T Whaley-Connell; Peter A McCullough; Rajnish Mehrotra Journal: Am J Kidney Dis Date: 2012-03 Impact factor: 8.860
Authors: E P O'Sullivan; A Bhargava; M O'Callaghan; U Buckley; T De Faoite; K Moynihan; H Thabit; C H Walsh; S Sreenan Journal: Ir J Med Sci Date: 2009-12 Impact factor: 1.568
Authors: Lynda A Szczech; Rebecca C Stewart; Hsu-Lin Su; Richard J DeLoskey; Brad C Astor; Chester H Fox; Peter A McCullough; Joseph A Vassalotti Journal: PLoS One Date: 2014-11-26 Impact factor: 3.240
Authors: Chi D Chu; Michael H Chen; Charles E McCulloch; Neil R Powe; Michelle M Estrella; Michael G Shlipak; Delphine S Tuot Journal: Kidney Med Date: 2021-06-01
Authors: Susanne Stolpe; Bernd Kowall; Christian Scholz; Andreas Stang; Cornelia Blume Journal: Int J Environ Res Public Health Date: 2021-11-09 Impact factor: 3.390
Authors: Kristine E Lynch; Ji Won Chang; Michael E Matheny; Alexander Goldfarb; Olga Efimova; Gregorio Coronado; Scott L DuVall Journal: BMC Nephrol Date: 2018-12-28 Impact factor: 2.388